Cargando…
Lipoprotein(a) Where Do We Stand? From the Physiopathology to Innovative Terapy
A number of epidemiologic studies have demonstrated a strong association between increasing lipoprotein a [Lp(a)] and cardiovascular disease. This correlation was demonstrated independent of other known cardiovascular (CV) risk factors. Screening for Lp(a) in the general population is not recommende...
Autores principales: | Iannuzzo, Gabriella, Tripaldella, Maria, Mallardo, Vania, Morgillo, Mena, Vitelli, Nicoletta, Iannuzzi, Arcangelo, Aliberti, Emilio, Giallauria, Francesco, Tramontano, Anna, Carluccio, Raffaele, Calcaterra, Ilenia, Di Minno, Matteo Nicola Dario, Gentile, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301358/ https://www.ncbi.nlm.nih.gov/pubmed/34356902 http://dx.doi.org/10.3390/biomedicines9070838 |
Ejemplares similares
-
Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021) -
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima–Media Thickness in Post-Menopausal Women
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021) -
EXTRACORPOREAL SHOCKWAVE TERAPY TO TREAT CHRONIC MUSCLE INJURY
por: Astur, Diego Costa, et al.
Publicado: (2015) -
Dyslipidemia in Transplant Patients: Which Therapy?
por: Iannuzzo, Gabriella, et al.
Publicado: (2022) -
An Untargeted Lipidomic Analysis Reveals Depletion of Several Phospholipid Classes in Patients with Familial Hypercholesterolemia on Treatment with Evolocumab
por: Anesi, Andrea, et al.
Publicado: (2021)